| Rous sarcoma virus |
| Virus classification |
| Group: |
Group VI (ssRNA-RT) |
| Order: |
Unassigned |
| Family: |
Retroviridae |
| Subfamily: |
Orthoretrovirinae |
| Genus: |
Alpharetrovirus |
| Species: |
Rous sarcoma virus |
This article is about Rous sarcoma virus, a cancer-causing retrovirus. It is not to be confused with Respiratory syncytial virus.
Rous sarcoma virus (RSV) is a retrovirus and is the first oncovirus to have been described: it causes sarcoma in chickens.
As with all retroviruses, it reverse transcribes its RNA genome into cDNA before integration into the host DNA.
Contents
- 1 History
- 2 Structure and genome
- 2.1 Src gene
- 2.2 RNA secondary structure
- 2.3 Gag protein
- 2.4 RSV envelope
- 3 Replication cycle
- 3.1 Cell entry
- 3.2 Transcription
- 4 References
- 5 External links
History
RSV was discovered in 1911 by Peyton Rous, working at Rockefeller University in New York City, by injecting cell free extract of chicken tumour into healthy Plymouth Rock chickens. The extract was found to induce oncogenesis. The tumour was found to be composed of connective tissue (a sarcoma).[1][2] Thus, RSV became known as the first oncogenic retrovirus that could be used to study the development of cancer molecularly.[3]
In 1958, Harry Rubin and Howard Temin developed an assay where chicken embryo fibroblasts could be altered morphologically by RSV infection. Two years later Temin concluded that the transformed morphology of the cells was controlled by a genetic property of RSV. At that time it was unknown, but currently the src gene is responsible for morphological transformation in healthy cells. During the 1960s, two findings emerged: replication-competent isolated viruses were related to RSV, but were non-transforming, and an isolated replication-defective strain of RSV was transformation-competent. These two findings gave rise to the notion that viral replication and malignant transformation are separate processes in RSV.[4]
Rous was awarded the Nobel Prize in Physiology or Medicine for the significance of his discovery in 1966.[5] Subsequently after, other oncogenic human viruses, such as Epstein-Barr virus were discovered. Furthermore, oncogenes were found initially in retroviruses and then in cells.[3]
Structure and genome
| Retroviral 3'UTR stability element |
|
| Predicted secondary structure of the Rous sarcoma virus retroviral 3'UTR stability element |
| Identifiers |
| Symbol |
? |
| Rfam |
RF01417 |
| Other data |
| RNA type |
Cis-reg |
RSV is a class VI enveloped virus with a positive sense RNA genome having a DNA intermediate.
RSV has four genes:
- gag – encodes capsid proteins
- pol – encodes reverse transcriptase
- env – encodes the envelope gene
- src – encodes a tyrosine kinase that attaches phosphate groups to the amino acid tyrosine in host cell proteins.
The RSV genome has terminal repeats enabling its integration into the host genome and also overexpression of RSV genes.
Src gene
Main article: v-Src
The src gene is oncogenic as it triggers uncontrolled growth in abnormal host cells. It was the first retroviral oncogene to be discovered.[6] It is an acquired gene, found to be present throughout the animal kingdom with high levels of conservation between species.
The src gene was taken up by RSV and incorporated into its genome conferring it with the advantage of being able to stimulate uncontrolled mitosis of host cells, providing abundant cells for fresh infection.
The src gene is not essential for RSV proliferation but it greatly increases virulence when present.
Src is a tyrosine kinase involved in regulation of cell growth and differentiation. It has an SH2 and SH3 domain, which are responsible for its activation and deactivation.[4]
RNA secondary structure
The RNA genome of RSV contains an extremely long 3' UTR that ranges between 5–7 kb in length which would usually direct it toward nonsense mediated decay (NMD) within the eukaryotic host cell. A conserved secondary structure element has been identified within the 3'UTR and is known as the Rous Sarcoma Virus Stability Element (RSE).[7] This element has been shown to prevent the degradation of the unspliced viral RNA.[7]
The RSE element was first identified in the genome of the Rous Sarcoma Virus but appears to be widely conserved across the avian retrovirus family. The RSE element is ~300 bp in length and located downstream of the gag natural translational termination codon. The secondary structure of the RSE element has been determined by RNAse digestion and SHAPE chemistry analysis.[8]
Other elements that have been identified in RSV include a primer binding site.[9]
Gag protein
Gag proteins are necessary for virion assembly and mature virus infection of the host cell. The gag protein (Pr76) for RSV contains 701 amino acids. It is cleaved by virus encoded protease, releasing products found in the infectious virion. These cleaved products include the matrix (MA), capsid (CA), and nucleocapsid (NC), which are able to enter other pathways to infect new cells.[10][11]
RSV envelope
RSV has an envelope which has one glycoprotein: env. Env is made up of gp85 and gp37, which are glycoproteins that assemble into oligomers. The function of env is to bind RSV to the host cell receptor and induce fusion with the target cell in a pH independent manner. The envelope is acquired during exocytosis. The virus buds or pushes on the plasma membrane, which allows it to leave the cell with a new outer membrane from the host cell.[10][12]
Replication cycle
Cell entry
There are two ways viruses can enter the host cell: cell receptor endocytosis or fusion. Endocytosis is the process where the virus binds a receptor on the target cell membrane, and the virus is taken into or endocytosed into the cell. Endocytosis can either be pH independent or pH dependent. Fusion occurs when the virus fuses together with the target cell membrane and releases its genome into the cell. RSV enters the host cell through fusion of the host cell membrane.[13]
Transcription
In order for the RSV genome transcription to occur, a primer is required. 4S RNA is the primer for RSV and 70S RNA serves as the template for DNA synthesis. DNA polymerase or Reverse transcriptase transcribes viral RNA into the full length DNA complement.[14]
References
- ^ Rous P (September 1910). "A Transmissible Avian Neoplasm (Sarcoma of the Common Fowl)". J. Exp. Med. 12 (5): 696–705. doi:10.1084/jem.12.5.696. PMC 2124810. PMID 19867354.
- ^ Rous P (April 1911). "A Sarcoma of the Fowl Transmissible by an Agent Separable from the Tumor Cells". J. Exp. Med. 13 (4): 397–411. doi:10.1084/jem.13.4.397. PMC 2124874. PMID 19867421.
- ^ a b Weiss RA, Vogt PK (November 2011). "100 years of Rous sarcoma virus". J. Exp. Med. 208 (12): 2351–5. doi:10.1084/jem.20112160. PMC 3256973. PMID 22110182.
- ^ a b Martin GS (June 2001). "The hunting of the Src". Nat. Rev. Mol. Cell Biol. 2 (6): 467–75. doi:10.1038/35073094. PMID 11389470.
- ^ Nobelprize.org The Nobel Prize in Physiology or Medicine 1966: Peyton Rous, retrieved 1 Jul 2012
- ^ Vogt PK (September 2012). "Retroviral oncogenes: a historical primer". Nat. Rev. Cancer 12 (9): 639–48. doi:10.1038/nrc3320. PMC 3428493. PMID 22898541.
- ^ a b Weil JE, Beemon KL (January 2006). "A 3' UTR sequence stabilizes termination codons in the unspliced RNA of Rous sarcoma virus". RNA 12 (1): 102–10. doi:10.1261/rna.2129806. PMC 1370890. PMID 16301601.
- ^ Weil JE, Hadjithomas M, Beemon KL (March 2009). "Structural characterization of the Rous sarcoma virus RNA stability element". J. Virol. 83 (5): 2119–29. doi:10.1128/JVI.02113-08. PMC 2643715. PMID 19091866.
- ^ Johnson M, Morris S, Chen A, Stavnezer E, Leis J (2004). "Selection of functional mutations in the U5-IR stem and loop regions of the Rous sarcoma virus genome". BMC Biol. 2: 8. doi:10.1186/1741-7007-2-8. PMC 428589. PMID 15153244.
- ^ a b Wills JW, Cameron CE, Wilson CB, Xiang Y, Bennett RP, Leis J (October 1994). "An assembly domain of the Rous sarcoma virus Gag protein required late in budding". J. Virol. 68 (10): 6605–18. PMC 237081. PMID 8083996.
- ^ Nadaraia-Hoke S, Bann DV, Lochmann TL, Gudleski-O'Regan N, Parent LJ (March 2013). "Alterations in the MA and NC domains modulate phosphoinositide-dependent plasma membrane localization of the Rous sarcoma virus Gag protein". J. Virol. 87 (6): 3609–15. doi:10.1128/JVI.03059-12. PMC 3592118. PMID 23325682.
- ^ Einfeld D, Hunter E (November 1988). "Oligomeric structure of a prototype retrovirus glycoprotein". Proc. Natl. Acad. Sci. U.S.A. 85 (22): 8688–92. Bibcode:1988PNAS...85.8688E. doi:10.1073/pnas.85.22.8688. PMC 282525. PMID 2847170.
- ^ Gilbert JM, Mason D, White JM (October 1990). "Fusion of Rous sarcoma virus with host cells does not require exposure to low pH". J. Virol. 64 (10): 5106–13. PMC 248002. PMID 2168989.
- ^ Dahlberg JE, Sawyer RC, Taylor JM, Faras AJ, Levinson WE, Goodman HM, Bishop JM (May 1974). "Transcription of DNA from the 70S RNA of Rous sarcoma virus. I. Identification of a specific 4S RNA which serves as primer". J. Virol. 13 (5): 1126–33. PMC 355423. PMID 4132919.
External links
- the Rous sarcoma virus (RSV) at rcn.com
- molecular expressions at magnet.fsu.edu
- Rous sarcoma virus at the US National Library of Medicine Medical Subject Headings (MeSH)
- Rfam entry for retroviral 3'UTR stability element
|
Virus: Retroviruses
|
|
| ssRNA-RT virus |
|
Retroviridae
|
|
Alpharetrovirus
|
- Avian sarcoma leukosis virus
- Rous sarcoma virus
|
|
|
Betaretrovirus
|
- Mouse mammary tumor virus
- Jaagsiekte sheep retrovirus
|
|
|
Deltaretrovirus
|
- Human T-lymphotropic virus (HTLV-1
- HTLV-2, 3, 4)
- Simian-T-lymphotropic virus (types 1-4)
- Bovine leukemia virus
|
|
|
Epsilonretrovirus
|
- Walleye epidermal hyperplasia virus
|
|
|
Gammaretrovirus
|
- Murine leukemia virus
- Abelson murine leukemia virus
- Friend virus
- Feline leukemia virus
- Koala retrovirus (KIDS)
- Xenotropic murine leukemia virus-related virus
|
|
|
Lentivirus
|
- HIV
- Simian immunodeficiency virus (SIV)
- Feline immunodeficiency virus (FIV)
- Puma lentivirus
- Equine infectious anemia
- Bovine immunodeficiency virus (BIV)
- Caprine arthritis encephalitis virus
- Visna virus
|
|
|
Spumavirus
|
- Simian foamy virus
- Human foamy virus
|
|
|
|
Other
|
- Metaviridae
- Pseudoviridae
|
|
|
| dsDNA-RT virus |
- Hepadnaviridae (Hepatitis B virus)
- Caulimoviridae
|
|
| Endogenous |
- ERVWE1
- HCP5
- Human teratocarcinoma-derived virus
|
|
